This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
Why Home Sales Are Worse Than Ever
Gina Heeb, finance reporter at The Wall Street Journal, joins us to discuss the current state of the real estate market and when things may turn around. Watch!
How Zoom Is Getting into the Telehealth and AI Business
CEO of Suki, Punit Singh, joins Cheddar to discuss how his company is partnering with Zoom to get into the telehealth space. Watch!
Find Out What One Expert Claims 'Is My Favorite Thing Apple Has Released This Year'
Managing Editor at Tom's Guide, Kate Kozuch, joins Cheddar to explain how Apple's AirPods now work as hearing aids and what she thinks of Apple Intelligence.
Silicon Valley's View of the Presidential Election
Does the majority of Silicon Valley agree with the likes of Elon Musk? Plus, how tech companies may fare under a Trump or Harris administration. Watch!
How TikTok Star Harry Sisson Thinks Social Media Helps Presidential Campaigns
Politics influencer, Harry Sisson, joins Cheddar to discuss social media, the presidential campaign and the issue of misinformation. Watch!
How One Man Experimented With A Wholesome Side Hustle on OnlyFans
Andrew Rummer joins Cheddar to discuss his experiment setting up an OnlyFans account with more wholesome content than others. Watch!
